Clinically relevant concentrations of β2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury

Critical Care Medicine

Volumn 32, Issue 7, 2004, Pages 1470-1476

  McAuley, Daniel F ^a   Frank, James A ^a   Fang, Xiaohui ^a   Matthay, Michael A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Albuterol enantiomers; Alveolar epithelium; Alveolar fluid clearance; Salmeterol

Indexed keywords

ALBUMIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUCLADESINE; ISOPRENALINE; SALBUTAMOL; SALMETEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; ENANTIOMER; LUNG CLEARANCE; LUNG EDEMA; LUNG ENDOTHELIUM; LUNG EXTRAVASCULAR FLUID; LUNG FLUID; LUNG INJURY; NONHUMAN; PERMEABILITY; PRIORITY JOURNAL; RAT;

ADENOSINE MONOPHOSPHATE; ADRENERGIC BETA-AGONISTS; ALBUTEROL; ANIMALS; EXTRAVASCULAR LUNG WATER; PULMONARY ALVEOLI; PULMONARY EDEMA; PULMONARY GAS EXCHANGE; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATORY DISTRESS SYNDROME, ADULT; STEREOISOMERISM;

EID: 3142721744     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000129489.34416.0E     Document Type: Article

References (44)

1. Matthay MA, Folkesson HG, Clerici C: Lung epithelial fluid transport and the resolution of pulmonary edema. Physiol Rev 2002; 82: 569-600
2. Matthay MA, Wiener-Kronish JP: Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am Rev Respir Dis 1990; 142:1250-1257
3. Ware LB, Matthay MA: Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001; 163:1376-1383
4. Sakuma T, Okaniwa G, Nakada T, et al: Alveolar fluid clearance in the resected human lung. Am J Respir Crit Care Med 1994; 150: 305-310
5. Sakuma T, Suzuki S, Usuda K, et al: Preservation of alveolar epithelial fluid transport mechanisms in rewarmed human lung after severe hypothermia. J Appl Physiol 1996; 80: 1681-1686
6. Sakuma T, Folkesson HG, Suzuki S, et al: Beta-adrenergic agonist stimulated alveolar fluid clearance in ex vivo human and rat lungs. Am J Respir Crit Care Med 1997; 155: 506-512
7. Berthiaume Y, Staub NC, Matthay MA: Beta-adrenergic agonists increase lung liquid clearance in anesthetized sheep. J Clin Invest 1987; 79:335-343
8. Berthiaume Y, Broaddus VC, Cropper MA, et al: Alveolar liquid and protein clearance from normal dog lungs. J Appl Physiol 1988; 65: 585-593
9. Jayr C, Garat C, Meignan M, et al: Alveolar liquid and protein clearance in anesthetized ventilated rats. J Appl Physiol 1994; 76: 2636-2642
10. Jayr C, Matthay MA: Alveolar and lung liquid clearance in the absence of pulmonary blood flow in sheep. J Appl Physiol 1991; 71: 1679-1687
11. Garat C, Meignan M, Matthay MA, et al: Alveolar epithelial fluid clearance mechanisms are intact after moderate hyperoxic lung injury in rats. Chest 1997; 111:1381-1388
12. Lasnier JM, Wangensteen OD, Schmilz LS, et al: Terbutaline stimulates alveolar fluid resorption in hyperoxic lung injury. J Appl Physiol 1996; 81:1723-9
13. Saldias FJ, Lecuona E, Comellas AP, et al: Beta-adrenergic stimulation restores rat lung ability to clear edema in ventilator-associated lung injury. Am J Respir Crit Care Med 2000; 162:282-287
14. Saldias FJ, Comellas A, Ridge KM, et al: Isoproterenol improves ability of lung to clear edema in rats exposed to hyperoxia. J Appl Physiol 1999; 87:30-35
15. Frank JA, Wang Y, Osorio O, et al: Beta-adrenergic agonist therapy accelerates the resolution of hydrostatic pulmonary edema in sheep and rats. J Appl Physiol 2000; 89: 1255-1265
16. Minnear FL, DeMichele MA, Moon DG, et al: Isoproterenol reduces thrombin-induced pulmonary endothelial permeability in vitro. Am J Physiol 1989; 257:H1613-H1623
17. Khimenko PL, Barnard JW, Moore TM, et al: Vascular permeability and epithelial transport effects on lung edema formation in ischemia and reperfusion. J Appl Physiol 1994; 77:1116-1121
18. Dowling RB, Rayner CF, Rutman A, et al: Effect of salmeterol on Pseudomonas aeruginosa infection of respiratory mucosa. Am J Respir Crit Care Med 1997; 155:327-336
19. Johnson M, Rennard S: Alternative mechanisms for long-acting beta(2)-adrenergic agonists in COPD. Chest 2001; 120:258-270
20. Matthay MA, Zimmerman GA, Esmon C, et al: Future research directions in acute lung injury: Summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med 2003; 167:1027-1035
21. Atabai K, Ware LB, Snider ME, et al: Aerosolized beta(2)-adrenergic agonists achieve therapeutic levels in the pulmonary edema fluid of ventilated patients with acute respiratory failure. Intensive Care Med 2002; 28: 705-711
22. Penn RB, Frielle T, McCullough JR, et al: Comparison of R-, S-, and RS-albuterol interaction with human beta 1- and beta 2-adrenergic receptors. Clin Rev Allergy Immunol 1996; 14:37-45
23. Frank JA, Gutierrez JA, Jones KD, et al: Low tidal volume reduces epithelial and endothelial injury in acid-injured rat lungs. Am J Respir Crit Care Med 2002; 165:242-249 (online supplement)
24. Folkesson HG, Matthay MA, Hebert CA, et al: Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. J Clin Invent 1995; 96:107-116
25. Pearce ML, Yamashita J, Beazell J: Measurement of pulmonary edema. Circ Res 1965; 16:482-488
26. Modelska K, Pittet JF, Folkesson HG, et al: Acid-induced lung injury. Protective effect of anti-interleukin-8 pretreatment on alveolar epithelial barrier function in rabbits. Am J Respir Crit Care Med 1999; 160:1450-1456
27. Takayama M, Ishibashi M, Ishii H, et al: Effects of neutrophil elastase inhibitor (ONO-5046) on lung injury after intestinal ischemia-reperfusion. J Appl Physiol 2001; 91: 1800-1807
28. Frank JA, Pittet JF, Lee H, et al: High tidal volume ventilation induces NOS2 and impairs cAMP-dependent airspace fluid clearance. Am J Physiol 2003; 284:L791-L798
29. Matthews JN, Altman DG, Campbell MJ, et al: Analysis of serial measurements in medical research. BMJ 1990; 300:230-235
30. Sakuma T, Tuchihara C, Ishigaki M, et al: Beta1-adrenoceptor stimulation by high-dose terbutaline downregulates terbutaline-stimulated alveolar fluid clearance in ex vivo rat lung. Exp Lung Res 2001; 27:453-468
31. Lotvall J, Palmqvist M, Arvidsson P, et al: The therapeutic ratio of R-albuterol is comparable with that of RS-albuterol in asthmatic patients. J Allergy Clin Immunol 2001; 108: 726-731
32. Pittet JF, Lu LN, Morris DG, et al: Reactive nitrogen species inhibit alveolar epithelial fluid transport after hemorrhagic shock in rats. J Immunol 2001; 166:6301-6310
33. Modelska K, Matthay MA, Brown LA, et al: Inhibition of beta-adrenergic-dependent alveolar epithelial clearance by oxidant mechanisms after hemorrhagic shock. Am J Physiol 1999; 276:L844-L857
34. Laffon M, Lu LN, Modelska K, et al: Alpha-adrenergic blockade restores normal fluid transport capacity of alveolar epithelium after hemorrhagic shock. Am J Physiol 1999; 277:L760-L768
35. Pittet JF, Brenner TJ, Modelska K, et al: Alveolar liquid clearance is increased by endogenous catecholamines in hemorrhagic shock in rats. J Appl Physiol 1996; 81: 830-837
36. Pittet JF, Wiener-Kronish JP, Serikov V, et al: Resistance of the alveolar epithelium to injury from septic shock in sheep. Am J Respir Crit Care Med 1995; 151:1093-1100
37. Pittet JF, Wiener-Kronish JP, McElroy MC, et al: Stimulation of lung epithelial liquid clearance by endogenous release of catecholamines in septic shock in anesthetized rats. J Clin Invest 1994; 94:663-671
38. Hirsch J, Hansen KC, Frank JA, et al: Effects of different ventilation strategies on the proteome of rat alveolar type II cells. Molecular and Cellular Proteomics, Sixth International Symposium on Mass Spectrometry in the Health & Life Sciences 2003; 2(7 Suppl):S24
39. Liu F, Verin AD, Borbiev T, et al: Role of cAMP-dependent protein kinase A activity in endothelial cell cytoskeleton rearrangement. Am J Physiol 2001; 280:L1309-L1317
40. Patterson CE, Lum H, Schaphorst KL, et al: Regulation of endothelial barrier function by the cAMP-dependent protein kinase. Endothelium 2000; 7:287-308
41. Gillissen A, Wickenburg D, van Zwoll D, et al: Beta-2-agonists have antioxidant function in vitro. 2. The effect of beta-2-agonists on oxidant-mediated cytotoxicity and on superoxide anion generated by human polymorphonuclear leukocytes. Respiration 1997; 64: 23-28
42. Llewellyn-Jones CG, Stockley RA: The effects of beta 2-agonists and methylxanthines on neutrophil function in vitro. Eur Respir J 1994; 7:1460-1466
43. Calhoun WJ, Stevens CA, Lambert SB: Modulation of superoxide production of alveolar macrophages and peripheral blood mononuclear cells by beta-agonists and theophylline. J Lab Clin Med 1991; 117:514-522
44. The Acute Respiratory Distress Syndrome Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for Acute Lung Injury and the Acute Respiratory Distress Syndrome. N Engl J Med 2000; 342:1301-1308